(PJT) PJT Partners - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US69343T1079
Strategic Advisory, Capital Markets, Restructuring, Shareholder Engagement
Dividends
| Dividend Yield | 0.59% |
| Yield on Cost 5y | 1.42% |
| Yield CAGR 5y | 49.53% |
| Payout Consistency | 97.0% |
| Payout Ratio | 15.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 32.3% |
| Value at Risk 5%th | 49.1% |
| Relative Tail Risk | -7.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.15 |
| Alpha | -6.86 |
| CAGR/Max DD | 1.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.430 |
| Beta | 1.023 |
| Beta Downside | 0.952 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.25% |
| Mean DD | 7.12% |
| Median DD | 5.67% |
Description: PJT PJT Partners November 04, 2025
PJT Partners Inc. (NYSE:PJT) is a New-York-based investment bank that delivers strategic, shareholder, capital-markets, and restructuring advisory to corporations, sponsors, institutional investors, and governments worldwide. Its service suite spans M&A (including contested deals and spin-offs), activist-defense and shareholder-engagement counsel, debt and equity financing, geopolitical risk advice, and private-fund fundraising.
Key operating metrics underscore its market position: FY 2023 revenue reached approximately $1.73 billion, with net income of $465 million and a deal-count of roughly 400 transactions, placing PJT among the top five U.S. M&A advisors by volume. The firm’s performance is closely tied to macro-economic drivers such as interest-rate trends (which influence financing activity) and corporate credit spreads (which affect restructuring demand). A notable sector catalyst is the surge in shareholder activism, which has boosted demand for PJT’s defense and engagement services.
For a deeper quantitative view of PJT’s valuation and risk profile, a look at ValueRay’s analyst toolkit can be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (178.1m TTM) > 0 and > 6% of Revenue (6% = 99.3m TTM) |
| FCFTA 0.31 (>2.0%) and ΔFCFTA 2.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 41.89% (prev 30.41%; Δ 11.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.33 (>3.0%) and CFO 566.3m > Net Income 178.1m (YES >=105%, WARN >=100%) |
| Net Debt (12.8m) to EBITDA (409.6m) ratio: 0.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 9.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (43.4m) change vs 12m ago -2.69% (target <= -2.0% for YES) |
| Gross Margin 31.92% (prev 30.21%; Δ 1.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.0% (prev 86.21%; Δ 14.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.32 (EBITDA TTM 409.6m / Interest Expense TTM 60.7m) >= 6 (WARN >= 3) |
Altman Z'' 5.31
| (A) 0.40 = (Total Current Assets 771.8m - Total Current Liabilities 78.2m) / Total Assets 1.72b |
| (B) 0.20 = Retained Earnings (Balance) 336.9m / Total Assets 1.72b |
| (C) 0.23 = EBIT TTM 383.6m / Avg Total Assets 1.64b |
| (D) 0.43 = Book Value of Equity 340.1m / Total Liabilities 788.7m |
| Total Rating: 5.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 90.76
| 1. Piotroski 8.0pt |
| 2. FCF Yield 7.99% |
| 3. FCF Margin 32.44% |
| 4. Debt/Equity 1.81 |
| 5. Debt/Ebitda 0.03 |
| 6. ROIC - WACC (= 163.4)% |
| 7. RoE 97.32% |
| 8. Rev. Trend 74.32% |
| 9. EPS Trend 42.79% |
What is the price of PJT shares?
As of December 14, 2025, the stock is trading at USD 169.83 with a total of 222,440 shares traded.
Over the past week, the price has changed by -3.53%, over one month by -0.26%, over three months by -7.47% and over the past year by +3.06%.
Over the past week, the price has changed by -3.53%, over one month by -0.26%, over three months by -7.47% and over the past year by +3.06%.
Is PJT a buy, sell or hold?
PJT Partners has received a consensus analysts rating of 2.67.
Therefor, it is recommend to hold PJT.
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the PJT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 177.5 | 4.5% |
| Analysts Target Price | 177.5 | 4.5% |
| ValueRay Target Price | 200.3 | 17.9% |
PJT Fundamental Data Overview December 05, 2025
Market Cap USD = 6.71b (6.71b USD * 1.0 USD.USD)
P/E Trailing = 25.7664
P/E Forward = 20.7039
P/S = 4.0456
P/B = 17.6018
P/EG = 1.36
Beta = 0.838
Revenue TTM = 1.66b USD
EBIT TTM = 383.6m USD
EBITDA TTM = 409.6m USD
Long Term Debt = 413.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 28.9m USD (from shortTermDebt, last fiscal year)
Debt = 413.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.72b USD (6.71b + Debt 413.2m - CCE 400.5m)
Interest Coverage Ratio = 6.32 (Ebit TTM 383.6m / Interest Expense TTM 60.7m)
FCF Yield = 7.99% (FCF TTM 537.2m / Enterprise Value 6.72b)
FCF Margin = 32.44% (FCF TTM 537.2m / Revenue TTM 1.66b)
Net Margin = 10.75% (Net Income TTM 178.1m / Revenue TTM 1.66b)
Gross Margin = 31.92% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 32.16% (prev 31.96%)
Tobins Q-Ratio = 3.91 (Enterprise Value 6.72b / Total Assets 1.72b)
Interest Expense / Debt = 4.11% (Interest Expense 17.0m / Debt 413.2m)
Taxrate = 17.59% (16.0m / 91.0m)
NOPAT = 316.1m (EBIT 383.6m * (1 - 17.59%))
Current Ratio = 9.87 (Total Current Assets 771.8m / Total Current Liabilities 78.2m)
Debt / Equity = 1.81 (Debt 413.2m / totalStockholderEquity, last quarter 228.6m)
Debt / EBITDA = 0.03 (Net Debt 12.8m / EBITDA 409.6m)
Debt / FCF = 0.02 (Net Debt 12.8m / FCF TTM 537.2m)
Total Stockholder Equity = 183.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.36% (Net Income 178.1m / Total Assets 1.72b)
RoE = 97.32% (Net Income TTM 178.1m / Total Stockholder Equity 183.0m)
RoCE = 64.34% (EBIT 383.6m / Capital Employed (Equity 183.0m + L.T.Debt 413.2m))
RoIC = 172.8% (NOPAT 316.1m / Invested Capital 183.0m)
WACC = 9.42% (E(6.71b)/V(7.12b) * Re(9.79%) + D(413.2m)/V(7.12b) * Rd(4.11%) * (1-Tc(0.18)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 30.87%
[DCF Debug] Terminal Value 75.24% ; FCFE base≈504.6m ; Y1≈595.7m ; Y5≈918.2m
Fair Price DCF = 477.5 (DCF Value 11.61b / Shares Outstanding 24.3m; 5y FCF grow 19.24% → 3.0% )
EPS Correlation: 42.79 | EPS CAGR: 5.38% | SUE: 1.62 | # QB: 1
Revenue Correlation: 74.32 | Revenue CAGR: 9.95% | SUE: 1.42 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.36 | Chg30d=+0.035 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=7.74 | Chg30d=+0.460 | Revisions Net=+5 | Growth EPS=+12.9% | Growth Revenue=+11.1%
P/E Trailing = 25.7664
P/E Forward = 20.7039
P/S = 4.0456
P/B = 17.6018
P/EG = 1.36
Beta = 0.838
Revenue TTM = 1.66b USD
EBIT TTM = 383.6m USD
EBITDA TTM = 409.6m USD
Long Term Debt = 413.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 28.9m USD (from shortTermDebt, last fiscal year)
Debt = 413.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.72b USD (6.71b + Debt 413.2m - CCE 400.5m)
Interest Coverage Ratio = 6.32 (Ebit TTM 383.6m / Interest Expense TTM 60.7m)
FCF Yield = 7.99% (FCF TTM 537.2m / Enterprise Value 6.72b)
FCF Margin = 32.44% (FCF TTM 537.2m / Revenue TTM 1.66b)
Net Margin = 10.75% (Net Income TTM 178.1m / Revenue TTM 1.66b)
Gross Margin = 31.92% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 32.16% (prev 31.96%)
Tobins Q-Ratio = 3.91 (Enterprise Value 6.72b / Total Assets 1.72b)
Interest Expense / Debt = 4.11% (Interest Expense 17.0m / Debt 413.2m)
Taxrate = 17.59% (16.0m / 91.0m)
NOPAT = 316.1m (EBIT 383.6m * (1 - 17.59%))
Current Ratio = 9.87 (Total Current Assets 771.8m / Total Current Liabilities 78.2m)
Debt / Equity = 1.81 (Debt 413.2m / totalStockholderEquity, last quarter 228.6m)
Debt / EBITDA = 0.03 (Net Debt 12.8m / EBITDA 409.6m)
Debt / FCF = 0.02 (Net Debt 12.8m / FCF TTM 537.2m)
Total Stockholder Equity = 183.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.36% (Net Income 178.1m / Total Assets 1.72b)
RoE = 97.32% (Net Income TTM 178.1m / Total Stockholder Equity 183.0m)
RoCE = 64.34% (EBIT 383.6m / Capital Employed (Equity 183.0m + L.T.Debt 413.2m))
RoIC = 172.8% (NOPAT 316.1m / Invested Capital 183.0m)
WACC = 9.42% (E(6.71b)/V(7.12b) * Re(9.79%) + D(413.2m)/V(7.12b) * Rd(4.11%) * (1-Tc(0.18)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 30.87%
[DCF Debug] Terminal Value 75.24% ; FCFE base≈504.6m ; Y1≈595.7m ; Y5≈918.2m
Fair Price DCF = 477.5 (DCF Value 11.61b / Shares Outstanding 24.3m; 5y FCF grow 19.24% → 3.0% )
EPS Correlation: 42.79 | EPS CAGR: 5.38% | SUE: 1.62 | # QB: 1
Revenue Correlation: 74.32 | Revenue CAGR: 9.95% | SUE: 1.42 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.36 | Chg30d=+0.035 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=7.74 | Chg30d=+0.460 | Revisions Net=+5 | Growth EPS=+12.9% | Growth Revenue=+11.1%
Additional Sources for PJT Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle